Elanco Launches Novel Multi-Species Treatment for Livestock Respiratory Diseases

First-of-its-kind treatment to be approved by FDA in more than a decade Pradalex now available to treat bovine and swine respiratory diseases GREENFIELD, Ind. (February 4, 2025) — Elanco Animal Health Incorporated announced today the availability of its latest innovation: Pradalex™ (pradofloxacin injection) for the treatment of bovine respiratory disease (BRD) and swine respiratory disease (SRD). […]